MENU
+Compare
SRPT
Stock ticker: NASDAQ
AS OF
Apr 1 closing price
Price
$61.91
Change
-$1.91 (-2.99%)
Capitalization
6.19B

SRPT Sarepta Therapeutics Forecast, Technical & Fundamental Analysis

Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases... Show more

Industry: #Biotechnology
SRPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for SRPT with price predictions
Apr 01, 2025

SRPT's RSI Oscillator stays in oversold zone for 5 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 15 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where SRPT advanced for three days, in of 296 cases, the price rose further within the following month. The odds of a continued upward trend are .

SRPT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on March 18, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on SRPT as a result. In of 82 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for SRPT turned negative on March 10, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 49 similar instances when the indicator turned negative. In of the 49 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SRPT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for SRPT entered a downward trend on April 01, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.932) is normal, around the industry mean (13.458). P/E Ratio (26.457) is within average values for comparable stocks, (64.587). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.867). Dividend Yield (0.000) settles around the average of (0.025) among similar stocks. P/S Ratio (3.511) is also within normal values, averaging (251.391).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. SRPT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SRPT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
SRPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

SRPT is expected to report earnings to rise 4.74% to $1.99 per share on April 30

Sarepta Therapeutics SRPT Stock Earnings Reports
Q1'25
Est.
$1.99
Q4'24
Beat
by $0.36
Q3'24
Beat
by $0.68
Q2'24
Beat
by $0.57
Q1'24
Beat
by $0.75
The last earnings report on February 26 showed earnings per share of $1.90, beating the estimate of $1.54. With 3.55M shares outstanding, the current market capitalization sits at 6.19B.
A.I. Advisor
published General Information

General Information

a developer of treatments for life-threatening illnesses and viruses

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
215 First Street
Phone
+1 617 274-4000
Employees
1314
Web
https://www.sarepta.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
AFLG33.800.11
+0.33%
First Trust Active Factor Large Cap ETF
UBND21.830.03
+0.12%
VictoryShares Core Plus Intmdt Bond ETF
VNAM16.02N/A
-0.03%
Global X MSCI Vietnam ETF
QPFF35.08-0.11
-0.30%
American Century Quality Preferred ETF
KBWB62.36-0.41
-0.65%
Invesco KBW Bank ETF

SRPT and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, SRPT has been loosely correlated with GLMD. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if SRPT jumps, then GLMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SRPT
1D Price
Change %
SRPT100%
-2.99%
GLMD - SRPT
51%
Loosely correlated
-1.39%
ALZN - SRPT
49%
Loosely correlated
+4.94%
XBIO - SRPT
48%
Loosely correlated
-5.75%
TECX - SRPT
46%
Loosely correlated
-4.91%
BMRN - SRPT
45%
Loosely correlated
-3.89%
More